Daniel O’day
Chief Executive Officer
Chief Executive Officer
Chugai Pharma
Japan
Biography
Daniel O’Day Chief Executive Officer of Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors 1987 Joined Roche Pharma USA 1995 Director Human Resources, Roche Pharma U.S.A. 1996 Director Product Marketing, Roche Pharma U.S.A. 1998 Business Unit Head, Arthritis and Respiratory, Roche Pharma Headquarters 1999 Lifecycle Leader Tamiflu, Roche Pharma Headquarters 2001 Head Corporate Planning, Roche Pharma Japan 2003 General Manager, Roche Pharma Denmark 2006 President & CEO of Roche Molecular Diagnostics 2010 COO Roche Diagnostics Division, Member of the Corporate Executive Committee 2012 COO Roche Pharmaceuticals Division, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors 2013 Director of the Company (to present) 2016 CEO Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors (to present)
Research Interest
Daniel O’Day Chief Executive Officer of Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors 1987 Joined Roche Pharma USA 1995 Director Human Resources, Roche Pharma U.S.A. 1996 Director Product Marketing, Roche Pharma U.S.A. 1998 Business Unit Head, Arthritis and Respiratory, Roche Pharma Headquarters 1999 Lifecycle Leader Tamiflu, Roche Pharma Headquarters 2001 Head Corporate Planning, Roche Pharma Japan 2003 General Manager, Roche Pharma Denmark 2006 President & CEO of Roche Molecular Diagnostics 2010 COO Roche Diagnostics Division, Member of the Corporate Executive Committee 2012 COO Roche Pharmaceuticals Division, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors 2013 Director of the Company (to present) 2016 CEO Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors (to present)
